Synapse loss in dementias

Journal of Neuroscience Research

Volumn 88, Issue 10, 2010, Pages 2083-2090

  Clare, Ryan ^a   King, Victoria G ^a   Wirenfeldt, Martin ^a   Vinters, Harry V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognitive impairment; Dementia; Synapse loss; Synaptic proteins; Synaptophysin

Indexed keywords

AMYLOID BETA PROTEIN; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANTIGEN SPECIFICITY; BINSWANGER ENCEPHALOPATHY; COGNITIVE DEFECT; CORRELATION ANALYSIS; DEMENTIA; DISEASE SEVERITY; FRONTOTEMPORAL DEMENTIA; HUMAN; IMMUNOCHEMISTRY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SHORT SURVEY; SYNAPSE; SYNAPTIC TRANSMISSION; TEMPORAL LOBE; ANIMAL; BRAIN; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; DEMENTIA; HUMANS; SYNAPSES;

EID: 77953631173     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22392     Document Type: Short Survey

References (59)

1. Bergeron C, Ranalli PJ, Miceli PN. 1987. Amyloid angiopathy in Alzheimer's disease. Can J Neurol Sci 14:564-569.
2. Blennow K, Bogdanovic N, Alafuzoff I, Ekman R, Davidsson P. 1996. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J Neural Transm 103:603-618. (Pubitemid 26383646)
3. Brown DF, Risser RC, Bigio EH, Tripp P, Stiegler A, Welch E, Eagan KP, Hladik CL, White CL III. 1998. Neocortical synapse density and Braak stage in the lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging. J Neuropathol Exp Neurol 57:955-960. (Pubitemid 28478005)
4. Brun A, Liu X, Erikson C. 1995. Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. Neurodegeneration 4:171-177.
5. Buttini M, Masliah E, Barbour R, Grajeda H, Motter R, Johnson-Wood K, Khan K, Seubert P, Freedman S, Schenk D, Games D. 2005. Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. J Neurosci 25:9096-9101. (Pubitemid 41500817)
6. Callahan LM, Coleman PD. 1995. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol Aging 16:311-314.
7. Clinton J, Forsyth C, Royston MC, Roberts GW. 1993. Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. Neuroreport 4:65-68. (Pubitemid 23066392)
8. Daly C, Ziff EB. 2002. Ca2+-dependent formation of a dynamin-synaptophysin complex: potential role in synaptic vesicle endocytosis. J Biol Chem 277:9010-9015.
9. Davies CA, Mann DM, Sumpter PQ, Yates PO. 1987. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78:151-164.
10. DeKosky ST, Scheff SW. 1990. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27:457-464.
11. Di Patre PL, Read SL, Cummings JL, Tomiyasu U, Vartavarian LM, Secor DL, Vinters HV. 1999. Progression of clinical deterioration and pathological changes in patients with Alzheimer disease evaluated at biopsy and autopsy. Arch Neurol 56:1254-1261. (Pubitemid 29473218)
12. Edelmann L, Hanson PI, Chapman ER, Jahn R. 1995. Synaptobrevin binding to synaptophysin: a potential mechanism for controlling the exocytotic fusion machine. EMBO J 14:224-231.
13. Ellison D, Love S, Chimelli L, Harding B, Lowe JS, Vinters HV. 2004. Neuropathology: a reference text of CNS pathology. London: Mosby. 549p.
14. Fernandez-Chacon R, Konigstorfer A, Gerber SH, Garcia J, Matos MF, Stevens CF, Brose N, Rizo J, Rosenmund C, Südhof TC. 2001. Synaptotagmin I functions as a calcium regulator of release probability. Nature 410:41-49. (Pubitemid 32225830)
15. Ferrer I. 1999. Neurons and their dendrites in frontotemporal dementia. Dement Geriatr Cogn Disord 10(Suppl 1):55-60.
16. Ferrer I. 2002. Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease. Cerebellum 1:213-222.
17. Geppert M, Goda Y, Hammer RE, Li C, Rosahl TW, Stevens CF, Südhof TC. 1994. Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell 79:717-727.
18. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG. 2006. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37:2220-2241.
19. Hamos JE, DeGennaro LJ, Drachman DA. 1989. Synaptic loss in Alzheimer's disease and other dementias. Neurology 39:355-361.
20. Hansen LA, Daniel SE, Wilcock GK, Love S. 1998. Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia. J Neurol Neurosurg Psychiatry 64:653-656.
21. Haruta T, Takami N, Ohmura M, Misumi Y, Ikehara Y. 1997. Ca 2+-dependent interaction of the growth-associated protein GAP-43 with the synaptic core complex. Biochem J 325:455-463.
22. Heinonen O, Soininen H, Sorvari H, Kosunen O, Paljarvi L, Koivisto E, Riekkinen PJ Sr. 1995. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience 64:375-384.
23. Honer WG. 2003. Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals. Neurobiol Aging 24:1047-1062.
24. Honer WG, Kaufmann CA, Davies P. 1992. Characterization of a synaptic antigen of interest in neuropsychiatric illness. Biol Psychiatry 31:147-158.
25. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L. 1999. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 96:3228-3233.
26. Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, Albert MS, Hyman BT, Irizarry MC. 2004. Early Ab accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62:925-931.
27. Ishibashi K, Tomiyama T, Nishitsuji K, Hara M, Mori H. 2006. Absence of synaptophysin near cortical neurons containing oligomer Aβ in Alzheimer's disease brain. J Neurosci Res 84:632-636.
28. Janz R, Goda Y, Geppert M, Missler M, Suβdhof TC. 1999. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron 24:1003-1016.
29. Kitamoto T, Shin RW, Doh-ura K, Tomokane N, Miyazono M, Muramoto T, Tateishi J. 1992. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 140:1285-1294.
30. Kumar-Singh S, Van Broeckhoven C. 2007. Frontotemporal lobar degeneration: current concepts in the light of recent advances. Brain Pathol 17:104-113.
31. Lipton AM, Cullum CM, Satumtira S, Sontag E, Hynan LS, White III CL, Bigio EH. 2001. Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias. Arch Neurol 58:1233-1239.
32. Liu XY, Brun A. 1996. Regional and laminar synaptic pathology in frontal lobe degeneration of non-Alzheimer type. Int J Geriatr Psychiatry 11:47-55.
33. Liu X, Passant U, Risberg J, Warkentin S, Brun A. 1999. Synapse density related to cerebral blood flow and symptomatology in frontal lobe degeneration and Alzheimer's disease. Dement Geriatr Cogn Disord 10(Suppl 1):64-70.
34. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J. 1999. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155:853-862. (Pubitemid 29426831)
35. Mackenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, Kovacs GG, Ghetti B, Halliday G, Holm IE, Ince PG, Kamphorst W, Revesz T, Rozemuller AJM, Kumar-Singh S, Akiyama H, Baborie A, Spina S, Dickson DW, Trojanowski JQ, Mann DMA. 2009. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 117:15-18.
36. Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA. 1991. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am J Pathol 138:235-246.
37. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH. 1996. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113-1124. (Pubitemid 26374873)
38. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. 2000. High-level neuronal expression of Ab1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20:4050-4058. (Pubitemid 30365675)
39. National Institutes of Health. 2008. Alzheimer's disease - fact sheet. Bethesda, MD: NIH Publ. No.08-6423.
40. Perdahl E, Adolfsson R, Alafuzoff I, Albert KA, Nestler EJ, Greengard P, Winblad B. 1984. Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multi-infarct dementia. J Neural Transm 60:133-141. (Pubitemid 14035430)
41. Reddy PH, Mani G, Park BS, Jacques J, Murdoch G, Whetsell W Jr, Kaye J, Manczak M. 2005. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J Alzheimers Dis 7:103-117. (Pubitemid 40592184)
42. Revuelta GJ, Rosso A, Lippa CF. 2008. Neuritic pathology as a correlate of synaptic loss in dementia with Lewy bodies. Am J Alzheimers Dis Other Demen 23:97-102.
43. Sabbagh MN, Corey-Bloom J, Tiraboschi P, Thomas R, Masliah E, Thal LJ. 1999. Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease. Arch Neurol 56:1458-1461.
44. Samuel W, Alford M, Hofstetter CR, Hansen L. 1997. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol 56:499-508. (Pubitemid 27463091)
45. Scheff SW, DeKosky ST, Price DA. 1990. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging 11:29-37.
46. Schlaf G, Salje C, Poethke R, Felgenhauer K, Mader M. 1996. A novel enzyme-linked immunosorbent assay for determination of synaptophysin as compared with other quantification procedures. J Neuroimmunol 67:59-65. (Pubitemid 26245704)
47. Selnes OA, Vinters HV. 2006. Vascular cognitive impairment. Nat Clin Pract Neurol 2:538-547.
48. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. 1997. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277:813-817. (Pubitemid 27111317)
49. Sollner T, Bennett MK, Whiteheart SW, Scheller RH, Rothman JE. 1993. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell 75:409-418. (Pubitemid 23335067)
50. Soontornniyomkij V, Lynch MD, Mermash S, Pomakian J, Badkoobehi H, Clare R, Vinters HV. 2009. Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol 20:459-467.
51. Südhof TC. 1995. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature 375:645-653.
52. Südhof TC. 2004. The synaptic vesicle cycle. Annu Rev Neurosci 27:509-547.
53. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
54. Valtorta F, Pennuto M, Bonanomi D, Benfenati F. 2004. Synaptophysin: leading actor or walk-on role in synaptic vesicle exocytosis? Bioessays 26:445-453.
55. Vinters HV. 1987. Cerebral amyloid angiopathy. A critical review. Stroke 18:311-324.
56. Vinters HV, Secor DL, Read SL, Frazee JG, Tomiyasu U, Stanley TM, Ferreiro JA, Akers MA. 1994. Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. Ultrastruct Pathol 18:333-348. (Pubitemid 24184171)
57. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, Chui HC. 2000. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 59:931-945.
58. Zhan SS, Beyreuther K, Schmitt HP. 1993. Vascular dementia in Spatz- Lindenberg's disease (SLD): cortical synaptophysin immunoreactivity as compared with dementia of Alzheimer type and non-demented controls. Acta Neuropathol 86:259-264. (Pubitemid 23275943)
59. Zhan SS, Beyreuther K, Schmitt HP. 1994. Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and nondemented controls. Dementia 5:79-87. (Pubitemid 24092439)